MESM Revenue and Competitors

Claim your profile

Chorley, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • MESM's estimated annual revenue is currently $24.1M per year.(i)
  • MESM's estimated revenue per employee is $251,000

Employee Data

  • MESM has 96 Employees.(i)
  • MESM grew their employee count by 2% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.3M5-50%N/AN/A
#2
$40.7M162-2%N/AN/A
#3
$30.4M121-2%N/AN/A
#4
$40.4M161-2%N/AN/A
#5
$12M48-27%N/AN/A
#6
$17.1M68-26%N/AN/A
#7
$21.3M85-14%N/AN/A
#8
$22.6M90-8%$17.5MN/A
#9
$12.6M50-12%N/AN/A
#10
$10.8M43-20%N/AN/A

MESM specialise in the Sourcing, Supply, Service and Calibration of medical equipment for Clinical Studies. We provide a Global service tailored to our customer's individual needs whereby we will Source any product required for your study offering options for hire and purchase. In addition we will manage and monitor your equipment through full life cycle management. At MESM we are dedicated to providing quality, reliable new Medical Equipment for continuous availability and reliability throughout your study. All equipment supplied is support by our service engineers performing Service, Calibration and maintenance as required. Our range of services include: 1. Sourcing product with Purchase and Hire options 2. Service, Calibration and Maintenance programs 3. Equipment Installation and Training 4. 24 Hour Technical Support 5. Storage, Logistics and Equipment Management 6. End of life Re-cycling www.mesm.com

keywords:N/A

N/A

Total Funding

96

Number of Employees

$24.1M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MESM News

2022-03-22 - mesm Tokyo, Autograph Collection Unveiled New Afternoon ...

mesm Tokyo, Autograph Collection Unveiled New Afternoon Exhibition, “Parasol,” on the Motif of Claude Monet's “Woman with a Parasol - Madame...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.3M1083%N/A
#2
$31.1M13065%N/A
#3
$51.4M16114%N/A
#4
$42.9M1634%N/A
#5
$40.9M169-34%N/A